Stocks making the biggest moves premarket: Dayforce, Sunrun, Tesla, Novo Nordisk and more

Premarket trading saw notable movements driven by corporate actions, regulatory approvals, and analyst upgrades. Dayforce surged over 24% on reports of potential acquisition talks by Thoma Bravo, while Soho House jumped more than 16% following a $2.7 billion privatization deal. Novo Nordisk gained 4% after its obesity drug Wegovy received FDA approval for a serious liver disease, and solar-related stocks Sunrun and Nextracker advanced on analyst upgrades and favorable tax guidance. Terawulf rose 9% on an AI expansion plan at its data center, backed by Google, though Tesla shares were marginally lower amid reports of increased lease discounts in the U.K. to address inventory.

Analysis

Premarket activity reveals strong event-driven catalysts across multiple sectors, with M&A speculation and definitive deals creating significant alpha. Dayforce surged over 24% on reports of acquisition talks with Thoma Bravo, while Soho House jumped more than 16% on a confirmed $2.7 billion privatization plan, signaling robust private equity appetite and potential valuation floors in the software and hospitality industries. The renewable energy sector received a notable boost from regulatory clarity, as favorable Treasury Department guidance on tax benefits catalyzed analyst upgrades and pushed Sunrun and Nextracker up by over 4%; Guggenheim's upgrade of Nextracker to 'buy' included a $74 price target, implying over 22% upside. In healthcare, Novo Nordisk gained 4% after securing FDA approval to expand the use of its blockbuster drug Wegovy to treat MASH, a serious liver disease, further solidifying its market dominance. Meanwhile, the AI infrastructure theme continues to drive performance, with Terawulf rising 9% on news of an AI-driven expansion at its data center campus backed by a $1.4 billion backstop from Google. In contrast, Tesla shares showed weakness, declining marginally on reports of steep lease discounts in the U.K. to clear inventory, indicating potential demand headwinds in the EV market.

Key Decisions for Investors

• The significant premiums in the Dayforce and Soho House deals suggest investors should screen for undervalued assets in the software and hospitality sectors that could become targets for private equity.
• Positive regulatory guidance and subsequent analyst upgrades for Sunrun and Nextracker signal a favorable inflection point for the solar industry, warranting a review of solar supply chain holdings.
• Novo Nordisk's expanded FDA approval for Wegovy presents a material change to its total addressable market, justifying a re-evaluation of its long-term revenue forecasts and competitive moat.
• The Terawulf announcement, backed by Google, validates the high-growth thesis for AI infrastructure, suggesting a closer look at data center operators and their suppliers.
• Reports of Tesla's discounting in the U.K. to manage inventory should be treated as a potential leading indicator of margin pressure, advising caution and a focus on upcoming delivery and sales data.